Personal Investment Vitae

Home > Personal Investment Vitae

AYA Personal Investment Vitae as of March 2026
Peter Prince @Peter Prince
Platinum member since January 2017

Location: United States

Gender: Male

Asset investment style: Quantitative technical analysis

Market capitalization:

$7,958,517talents

Virtual portfolio value:

$4,966,182talents

Net overall return per annum:

19.03%

AYA current rank order:

#6

Asset investment philosophy:
Peter Prince trades U.S. stocks with the top #401 to #500 positive alpha signals.

Top 10 profitable stock transactions since January 2020Strategy

Symbol Company Buy Sell Share Volume Return (%) Profit ($)
VATE INNOVATE Corp. Common Stock $0.53 $4.14 76,537 +681.13% $276,299
RMBL RumbleOn Inc. Class B Common Stock $0.36 $7.95 14,872 +2,108.33% $112,878
TEAM Atlassian Corporation Class A Common Stock $28.92 $224.83 201 +677.42% $39,378
SHOP Shopify Inc. Class A Subordinate Voting Shares $56.05 $426.82 104 +661.50% $38,560
AXSM Axsome Therapeutics Inc. Common Stock $4.60 $31.75 1,267 +590.22% $34,399
LSCC Lattice Semiconductor Corporation Common Stock $6.97 $48.04 836 +589.24% $34,335
SQ Block Inc. Class A Common Stock $14.50 $99.54 402 +586.48% $34,186
FIVN Five9 Inc. Common Stock $16.31 $110.10 357 +575.05% $33,483
TRNS Transcat Inc. Common Stock $11.35 $73.00 513 +543.17% $31,626
GLOB Globant S.A. Common Shares $34.57 $215.99 168 +524.79% $30,479
Sum $665,623

Top 10 current stock portfolio positions as of March 2026Strategy

Top 20 influencers

#1 - #5 #6 - #10 #11 - #15 #15 - #20
@alin
@Chanel Holden
@Andy Yeh Alpha

Top 20 favorite stocks

#1 - #5 #6 - #10 #11 - #15 #15 - #20
$PSKY $DIS
$WBD $NFLX
$BILI
$IQ
$AAPL

Blog+More

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

Jacob Miramar

2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history.

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be

+See More

Colin Camerer, George Loewenstein, and Matthew Rabin assess the recent advances in the behavioral economic science.

James Campbell

2023-09-14 09:28:00 Thursday ET

Colin Camerer, George Loewenstein, and Matthew Rabin assess the recent advances in the behavioral economic science.

Colin Camerer, George Loewenstein, and Matthew Rabin assess the recent advances in the behavioral economic science. Colin Camerer, George Loewenstei

+See More

Tech titans from Apple and Amazon to Microsoft and Google can benefit from the G.O.P. tax reform.

James Campbell

2017-12-07 08:31:00 Thursday ET

Tech titans from Apple and Amazon to Microsoft and Google can benefit from the G.O.P. tax reform.

Large multinational tech firms such as Facebook, Apple, Microsoft, Google, and Amazon can benefit much from the G.O.P. tax reform. A recent stock research r

+See More

Agile lean enterprises break down organizational silos to promote smart collaboration for better profitability and customer loyalty.

Laura Hermes

2020-11-03 08:30:00 Tuesday ET

Agile lean enterprises break down organizational silos to promote smart collaboration for better profitability and customer loyalty.

Agile lean enterprises break down organizational silos to promote smart collaboration for better profitability and customer loyalty. Heidi Gardner (2017

+See More

We need crowdfunds to support our next responsive web design and iOS and Android app development.

Andy Yeh Alpha

2019-01-13 12:37:00 Sunday ET

We need crowdfunds to support our next responsive web design and iOS and Android app development.

We need crowdfunds to support our next responsive web design and iOS and Android app development. Upon successful campaign completion, we will provide an eb

+See More

What are the mainstream legal origins of President Trump's new tariff policies?

Amy Hamilton

2025-06-13 08:23:00 Friday ET

What are the mainstream legal origins of President Trump's new tariff policies?

What are the mainstream legal origins of President Trump’s new tariff policies? We delve into the mainstream legal origins of President Trump&rsquo

+See More